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A very short distance between the
aortic annulus and the left main
coronary artery (LMCA) ostium is
typically a contraindication for trans-
catheter aortic valve implantation
(TAVI) given concerns of potential
coronary obstruction following
their deployment. We report the
case of an 85-year-old patient
admitted to our hospital with acute
cardiac decompensation. Transthor-
acic echocardiography demon-
strated severe aortic valve stenosis
(aortic valve area: 0.7 cm2) and LV
ejection fraction of 40%. Coronary
angiography showed minimal coron-
ary artery disease. The patient was
considered unsuitable for conven-
tional cardiac surgery due to several
comorbidities, however, a planning
computed tomography for TAVI revealed an extremely low-lying LMCA (6.3 mm from the aortic annulus; Panels A and B) and calcified,
bulky aortic valve leaflets [Panels B, C, and E (red asterisk)]. Because of repeated haemodynamic instabilities, we decided to first
perform a balloon aortic valvuloplasty with a guidewire and angioplasty balloon in place in the LMCA (Panel E) as a precaution against ob-
struction. This was followed by TAVI with an Edwards-SAPIEN-XT 29 mm valvewithout anyobstruction noted due to awide aortic sinus of
Valsalva (39 mm, Panels D and F ). No paravalvular leak was noted and the patient recovered rapidly.
Coronary obstruction is a rare, but severe complication following TAVI. A short distance (,10 mm) between the aortic annulus and
LMCA has been considered a contraindication in recent guidelines. In the first multi-centre registry of coronary obstruction following
TAVI, both the distance of the aortic annulus to the LMCA and the width of the aortic sinus of Valsalva were determined to be risk
factors. The present case illustrates that TAVI can be successfully performed in selected patients with a low LMCA and bulky, calcified
aortic valve leaflets in the presence of a very wide aortic sinus of Valsalva, however, precaution with a guidewire and angioplasty balloon
in place is recommended.
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